Intragastric balloon treatment of obesity: Long-term results and patient satisfaction

Haddad, Aline El; Rammal, Mohammad; Soweid, Assaad; Shararra, Ala I; Daniel, Fady; Rahal, Mahmoud; Shaib, Yasser H.

doi:10.5152/tjg.2019.17877

Cited by 21 publications

(10 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…76 Despite this initial weight loss, several studies have found that long-term weight-loss maintenance in patients that have had intragastric balloons is often unsustainable. [77][78][79] In addition, complications arising from intragastric balloons include epigastric pain, nausea, gastric perforation, and bowel obstruction due to spontaneous deflation of the device. 80 Aspiration therapy is a hybrid endoscopic and percutaneous procedure that aims to reduce a patient's caloric intake through direct aspiration of undigested food from the stomach.…”

Section: Endoscopic Weight Loss Therapiesmentioning

confidence: 99%

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

Danda

Bailey

Weiss

2020

Digestive Disease Interventions

View full text Add to dashboard Cite

The obesity epidemic is a growing public health concern that has a severe effect on the health care system with significant morbidity, mortality, and cost. Treatment options for obesity include lifestyle modifications, pharmacotherapy, and bariatric surgery. Newer, less-invasive therapies including endoscopic bariatric procedures have been developed in recent years to fill the treatment gap that exists between noninvasive approaches and surgery. Bariatric artery embolization (BAE) is a novel minimally invasive endovascular procedure that has been developed to treat obesity. Recent evidence has suggested that bariatric embolization is well tolerated and can induce clinically significant weight loss through a hormonally mediated mechanism. This article will review existing preclinical and clinical data, and explore future directions of the endovascular treatment of obesity.

show abstract

Section: Endoscopic Weight Loss Therapiesmentioning

confidence: 99%

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

Danda

Bailey

Weiss

2020

Digestive Disease Interventions

View full text Add to dashboard Cite

show abstract

“…The benefits of EBMTs are discussed in other parts of this series of articles. When used as monotherapy, however, EBMTs have been somewhat limited by modest weight loss and metabolic benefits, weight regain, variable patient satisfaction, and minimal (if any) insurance coverage [5][6][7][8][9][10][11]. This is similar to monotherapy with obesity pharmacotherapy, for which modest outcomes and poor insurance coverage have also limited utilization.…”

Section: Introductionmentioning

confidence: 99%

Combining obesity pharmacotherapy with endoscopic bariatric and metabolic therapies

Kahan

Saunders

Kaplan

2020

Techniques and Innovations in Gastrointestinal Endoscopy

View full text Add to dashboard Cite

Endoscopic bariatric and metabolic therapies (EBMT) are rarely used in the United States. Compared with EBMTs alone, combining EBMTs with obesity pharmacotherapy may increase the magnitude and durability of weight loss and ultimately may contribute to increased patient satisfaction and EBMT utilization. Though combination therapy is frequently used in clinical practice, few published studies of combination EBMT/pharmacotherapy are available. Available studies and abstracts suggest that combination strategies are promising, but further research and clinical trials are needed. This article will review available obesity pharmacotherapy options and describe current data on combining EBMT and pharmacotherapy.

show abstract

“…However, there are conflicting information about the effectiveness of IGB application in the literature. [11][12][13] It is very important to know which factors affect the success of IGB. Because defining these factors well will allow selection of right patients to undergo IGB application.…”

mentioning

confidence: 99%

“…IGB has been of interest to patients because it is less invasive, reproducible, and reversible compared with other surgical procedures. However, there are conflicting information about the effectiveness of IGB application in the literature 11–13. It is very important to know which factors affect the success of IGB.…”

mentioning

confidence: 99%

Factors of Affecting the Success of Intragastric Balloon

Turan

Katar

Ersoy

2023

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

Background: Our aim was to determine the efficacy and safety of intragastric balloon (IGB) application and the factors affecting its success by evaluating the results of patients who underwent IGB.Materials and Methods: A total of 277 consecutive patients that underwent IGB between January 2019-September 2020 in our clinic were evaluated. Patients' demographic data, height and weight before the IGB procedure, weight at 6 and 12 months after the procedure, follow-up period, complication status, and whether they received dietician's assistance during the follow-up were recorded.Results: In 5 (1.8%) patients, IGB was removed for various reasons before the standard period of 6 months. The mean age of the patients was 35.6 ± 9.5 years, the mean baseline weight and body mass index (BMI) was 92.6 ± 14 kg and 33.5 ± 5.4 kg/m 2 respectively. The mean follow-up time was 13 ± 4.9 months, whereas in 146(53.6%) patients the follow-up was ≥ 12 months. In the 6-month follow-up, the mean %excess weight loss and %body weight loss were 65.65 ± 25.19% and 14.69 ± 6.96%, respectively, whereas at the 12-month follow-up they were 32.38 ± 24.79% and 6.56 ± 5.31%, respectively. High BMI (odds ratio = 1.2, 95% CI = 1.0-1.2) and not receiving dietitian's assistance (odds ratio = 8.5, 95% CI = 3.1-23.7) were independent risk factors for unsuccessful IGB application at both 6-month and 12-month follow-ups. Conclusion:IGB application is a relatively effective and safe weight loss treatment for overweight and obese individuals. High BMI and not getting help from a dietician are risk factors for failure of IGB. To increase compliance with dieticians and therefore success of IGB application, patients should undergo psychiatric evaluation before IGB procedure, and receive psychiatric support, if necessary.

show abstract

Intragastric balloon treatment of obesity: Long-term results and patient satisfaction

Abstract: Stem cells for pancreatitis 425 Gastric injury and bacterial overgrowth 433 The effect of visceral fat on SMA configuration 451 Antiplatelet agents in ulcerative colitis 459 Differentiation of BMSCs into intestinal ce 466 GERDOFF ® efficacy in patients with GERD

Cited by 21 publications

References 23 publications

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

A Review of Past and Present Weight Loss Strategies and the Potential Role of Bariatric Arterial Embolization

Combining obesity pharmacotherapy with endoscopic bariatric and metabolic therapies

Factors of Affecting the Success of Intragastric Balloon

Contact Info

Product

Resources

About